Endostar/PD-1 Inhibitors Combined With PP for Advanced NSCLC
NCT04063449
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
170
Enrollment
OTHER
Sponsor class
Conditions
Non-squamous Non-small Cell Lung Cancer
Interventions
DRUG:
endostar/PD-1 inhibitor
DRUG:
endostar
Sponsor
Dong Wang